DOCS
Doximity, Inc.
NYSE Healthcare United States
28,58 $US
+2.33% today
-33.98% YTD · -60.71% 1Y
20
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
28
Hedge funds tracked
Latest available SEC 13F filings
59
/ 100
MIXED

Analysis Doximity, Inc. (DOCS) — Kairos Score 59/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About Doximity, Inc.

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Key info

👔
CEO
Mr. Jeffrey A. Tangney
📍
HQ
500 3rd Street, Suite 510, San Francisco, CA, 94107, United States
👥
Employees
880
💰
Market cap
5 094 270 000,00 $US
📊
P/E
30.5
💸
Dividend yield
—

🕴️ Insider activity (90 days)

20 transactions — 0 buys and 7 sales reported by Doximity, Inc. executives.

WK
Wampler Kira Scherer
2026-10-01
Other
WK
Wampler Kira Scherer
2026-10-01
Sell
YW
Yang Watkin Phoebe L.
2026-09-30
Sell

🏦 Hedge Funds

28 institutional funds report a position on DOCS in their latest SEC quarterly filing.

VANGUARD GROUP INC
BlackRock, Inc.
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
D. E. Shaw & Co., Inc.

📰 Recent news

15 recent articles on DOCS.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Detection of clustered purchases or sales by several executives in the same stock.

🏦

13F Hedge Funds

Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot marked changes in search interest around the stocks being followed.

📧

Email alerts

Create your watchlist and receive a brief of events affecting your tickers.

Companies in the same sector as Doximity, Inc.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of DOCS on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 20 insider transactions over 90 days
✅ All 28 detected institutional funds
✅ Thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ Available history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + recent earnings
See full analysis →
Analyze other tickers for free →

Free signup · Pro €19/month or €190/year